National Cancer Institute (NCI): all 3,554 studies

Page 36 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the PancreasCompletedNCT00001431Phase 1
• A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in LymphomasCompletedNCT00001430Phase 2
• A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal CancerCompletedNCT00001428Phase 2
• A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and CisplatinCompletedNCT00001427Phase 2
• A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2
• Evaluation and Natural History of Children With Cancer and AIDSCompletedNCT00001424
• Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory MalignancyCompletedNCT00001387Phase 1
• Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus InfectionCompletedNCT00001386Phase 1
• Positron Emission Tomography in Patients With Breast CancerCompletedNCT00001385
• A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer PatientsCompletedNCT00001384Phase 2
• A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833CompletedNCT00001383Phase 1
• A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the ProstateCompletedNCT00001382Phase 1
• A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the BladderCompletedNCT00001381Phase 1
• A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast CancerCompletedNCT00001378Phase 1
• Familial Prostate CancerCompletedNCT00001377
• A Pilot Study of Topical Antiflammin-2 for PsoriasisCompletedNCT00001371
• A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic DiseaseCompletedNCT00001341Phase 1
• A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical ResectionCompletedNCT00001339Phase 2
• A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast CancerCompletedNCT00001338Phase 3
• In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in PatientsCompletedNCT00001336
• New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and NeuroblastomaCompletedNCT00001335Phase 2
• Phase I Study of Intrathecal TopotecanCompletedNCT00001333Phase 1
• Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal CarcinomatosisCompletedNCT00001332Phase 1
• A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833CompletedNCT00001302Phase 1
• Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term SurvivorsCompletedNCT00001301
• A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue SarcomaCompletedNCT00001300Phase 3
• A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal DysfunctionCompletedNCT00001298Phase 1
• A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity MelanomaCompletedNCT00001296Phase 3
• Continuing Care and Treatment for Patients With Cancer/AIDS/Skin DiseaseCompletedNCT00001295
• Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility AntigensCompletedNCT00001294
• Study of Scaling Disorders and Other Inherited Skin DiseasesCompletedNCT00001292
• A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer PatientsCompletedNCT00001272Phase 1
• A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell LymphomaCompletedNCT00001271Phase 1
• Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and LymphomaCompletedNCT00001270Phase 1
• Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast CancerCompletedNCT00001269Phase 1
• A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-DideoxyinosineCompletedNCT00001267Phase 3
• A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate CarcinomaCompletedNCT00001266Phase 2
• Phase I Study of Intrathecal MafosfamideCompletedNCT00001251Phase 1
• Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized TrialCompletedNCT00001250Phase 2
• Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-TacCompletedNCT00001249Phase 1
• Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast CancerCompletedNCT00001239Phase 2
• Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell LymphomasCompletedNCT00001237Phase 2
• Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III StudyCompletedNCT00001217Phase 3
• Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic VaccinesCompletedNCT00001210
• A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal TumorsCompletedNCT00001209Phase 1
• A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast CancerCompletedNCT00001193Phase 2
• The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue TumorsCompletedNCT00001189Phase 2
• The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the ExtremitiesCompletedNCT00001188Phase 2
• Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal VolunteersCompletedNCT00001164
• Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of CancerActive, not recruitingNCT00001163
• Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune SystemCompletedNCT00001158
• Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal VolunteersCompletedNCT00001150
• A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV InfectionCompletedNCT00000652Phase 1
• Women's Health Trial: Feasibility Study in Minority PopulationsCompletedNCT00000481Phase 3

← National Cancer Institute (NCI) overview and focus areas